Afuco™ Anti-Human CHRDL1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-CHRDL1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies binding to CHRDL-1 are used to treat a variety of adipose, glucose, cardiac, and related diseases and disorders.
Supplier Creative Biolabs
Product # AFC-155CL
Pricing Inquiry
Host Human
Target CHRDL1
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback